Physiological Effects of Creatine Supplementation in Active Males

NCT ID: NCT03003988

Last Updated: 2017-01-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was designed to examine how different forms of creatine impact active males.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study examined the effects of different formulations of creatine nitrate on muscle creatine content, body composition, anaerobic exercise capacity, bench press performance and clinical chemistry panels in recreationally active males.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dietary Supplementation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Creatine monohydrate

Creatine monohydrate (6.0 g.) + dextrose (0.5 g.)

Group Type EXPERIMENTAL

Creatine monohydrate

Intervention Type DIETARY_SUPPLEMENT

Creatine monohydrate (6.0 g) + dextrose (0.5 g)

Creatine nitrate

Creatine nitrate (5.0 g. creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio).

Group Type ACTIVE_COMPARATOR

Creatine nitrate

Intervention Type DIETARY_SUPPLEMENT

Creatine nitrate (5.0 g creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio)

Placebo

6.5 g. dextrose

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo (6.5 g dextrose)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Creatine monohydrate

Creatine monohydrate (6.0 g) + dextrose (0.5 g)

Intervention Type DIETARY_SUPPLEMENT

Creatine nitrate

Creatine nitrate (5.0 g creatine monohydrate + 1.5 g. creatine nitrate that provides 1.0 g. of creatine and 0.5 g. nitrate in 2:1 ratio)

Intervention Type DIETARY_SUPPLEMENT

Placebo

Placebo (6.5 g dextrose)

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* participants are apparently healthy and recreationally active males between the ages of 18 and 40;
* participants will need to have at least six months immediate prior history of resistance training on the bench press and leg press or squat;

Exclusion Criteria

* participants have a history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease;
* participants are currently using prescription medications;
* participants have a history of smoking;
* participants drink excessively (i.e., 12 drinks per week or more);
* participants have a recent history of creatine supplementation within six weeks of the start of supplementation;
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nutrabolt

INDUSTRY

Sponsor Role collaborator

Texas A&M University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard B Kreider, PhD

Role: PRINCIPAL_INVESTIGATOR

Texas A&M University

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB2014-0503FX

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Creatine and Motor Skill Acquisition
NCT05201651 UNKNOWN EARLY_PHASE1